Detalles de la búsqueda
1.
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
Br J Cancer
; 130(8): 1249-1260, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361045
2.
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 35-45, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36085390
3.
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer.
Gynecol Oncol
; 166(2): 334-343, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35738917
4.
ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 46-47, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335272
5.
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer.
Neoplasia
; 44: 100934, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37703626
6.
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma.
Hum Pathol
; 141: 158-168, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37742945
7.
Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging.
Cancers (Basel)
; 13(7)2021 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33806030
Resultados
1 -
7
de 7
1
Próxima >
>>